[
1. Veeran Subramaniam, Gregory Y H Lip, “Hypertension to heart failure: a pathophysiological spectrum relating blood pressure, drug treatments and stroke”; Expert Rev Cardiovasc Ther. 2009 Jun;7(6):703-13.doi: 10.1586/erc.09.4310.1586/erc.09.4319505285
]Search in Google Scholar
[
2. Arun Kannan, Rajesh Janardhanan, “Hypertension as a risk factor for “Curr Hypertens Rep. 2014 Jul;16(7):447.doi: 10.1007/s11906-014-0447-710.1007/s11906-014-0447-724792121
]Search in Google Scholar
[
3. Fabian Knebel, Ingolf Schimke, Kathleen Pliet, Sebastian Schattke, Salim Martin, Adrian C Borges, Gert Baumann; “NT-pro BNP in acute heart failure: correlationwith invasively measured. 2005 Jun;11(5 Suppl):S38-41. doi: 10.1016/j.cardfail.2005.04.012.10.1016/j.cardfail.2005.04.01215948099
]Search in Google Scholar
[
4. Frederick A. Masoudi, MD, MSPH, FACC, FAHA reviewing Januzzi JL Jr et al.”Ëmpiric NT-pro BNP cut points for diagnosing acute heart failure”; J Am Coll Cardiol 2018 Mar 20 McCullough PA and Kluger AY. J Am Coll Cardiol 2018 Mar 20
]Search in Google Scholar
[
5. Acute and chronic heart failure guidelines; EHJ (2016) 37 (27):2129-2200 - https://doi.org/10.1093/eurheartj/ehw12810.1093/eurheartj/ehw12827206819
]Search in Google Scholar
[
6. Milos Parovic, and all; “NT-pro BNP is a weak indicator of cardiac function and haemodynamic response to exercise in chronic heart failure”; ESC Heart Fail. 2019 Apr;6(2):449-454. doi: 10.1002/ehf2.12424. Epub 2019 Feb 20.10.1002/ehf2.12424643742930788904
]Search in Google Scholar
[
7. Miguel Rivera, and all; “NT-pro BNP levels and hypertension. Their importance in diagnosis of heart failure”; Rev Esp Cardiol. 2004 May; 57(5):396-402.10.1016/S1885-5857(06)60170-9
]Search in Google Scholar
[
8. Gerald F. Fletcher, and all; “Exercise standards for testing and training A scientific statement from the American Heart Association”, Circulation, Volume 128, Issue 8, 20 August 2013, Pages 873-934, https://doi.org/10.1161/CIR.0b013e31829b5b4410.1161/CIR.0b013e31829b5b4423877260
]Search in Google Scholar
[
9. Roberto M. Lang, and all; “Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging”, European Heart Journal Cardiovascular Imaging (2015) 16, 233271 doi:10.1093/ehjci/jev01410.1093/ehjci/jev01425712077
]Search in Google Scholar
[
10. Emmanuel Akintoye, and all; “National trends in admission and In-hospital mortality of patients with heart failure in the United States (2001 2014)”; JAMA, 29 Nov 2017, vol. 6, nr. 12; https://doi.org/10.1161/JAHA.117.00695510.1161/JAHA.117.006955577901429187385
]Search in Google Scholar
[
11. Gyu Chul Oh & Hyun-Jai Cho, and all; “Blood pressure and heart failure”; Clinical Hypertension volume 26, Article number: 1 (2020)10.1186/s40885-019-0132-x693933131908841
]Search in Google Scholar
[
12. Hamasaki H, “The effects of exercise on Natriuretic Peptides in individuals without heart failure”, Sports (Basel), June 201610.3390/sports4020032596891429910280
]Search in Google Scholar
[
13. Olsen M.H., and all.” N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy” A LIFE study. J. Hypertens. 2004;22:15971604. doi: 10.1097/01.hjh.0000125451.28861.2a.10.1097/01.hjh.0000125451.28861.2a15257184
]Search in Google Scholar
[
14. Neumayr G., and all; “ Effect of competitive marathon cycling on plasma N-terminal pro-brain natriuretic peptide and cardiac troponin T in healthy recreational cyclists”. Am. J. Cardiol. 2005;96:732735. doi: 10.1016/j.amjcard.2005.04.05410.1016/j.amjcard.2005.04.05416125505
]Search in Google Scholar
[
15. Shihui Fu, and all; “Synthesis, secretion, function, metabolism ad application of natriuretic peptides in heart failure”, Journal of Biological Engineering volume 12, Article number: 2 (2018)10.1186/s13036-017-0093-0576698029344085
]Search in Google Scholar
[
16. Braunwald E, “Medical progress: Biomarkers in heart failure”, NEJM 2018; 358; 2148-215910.1056/NEJMra080023918480207
]Search in Google Scholar
[
17. Eun-Hee Nah, and all; “Plasma NT-pro BNP levels associated with cardiac structural abnormalities in asymptomatic health examinees with preserved ejection fraction: a retrospective cross-sectional study”, BMJ Open. 2019 Apr 20;9(4):e026030. doi: 10.1136/bmjopen-2018-026030.10.1136/bmjopen-2018-026030650028131005928
]Search in Google Scholar
[
18. M N Islam, and all; “Association of diastolic dysfunction with N-terminal pro-B-_type natriuretic peptide level in heart failure patients with preserved ejection fraction”; Mymensingh Med J. 2019 Apr;28(2):333-346.
]Search in Google Scholar
[
19. Hyungseop Kim, and all; “The correlation of left atrial volume index to the level of N-terminal pro-BNP in heart filure with a preserved ejection fraction”; Echocardiography. 2008 Oct;25(9):961-7. doi: 10.1111/j.1540-8175.2008.00717.x. Epub 2008 Sep 210.1111/j.1540-8175.2008.00717.x18771554
]Search in Google Scholar
[
20. Olsen MH, Wachtell K, Tuxen C, Fossum E, Bang LE, Hall C, Ibsen H, Rokkedal J, Devereux RB, Hildebrandt PR.J “Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy”.;.J Hypertens. 2005 May;23(5):1083-90. doi: 10.1097/01.hjh.0000166851.18463.85.10.1097/01.hjh.0000166851.18463.8515834296
]Search in Google Scholar
[
21. Gheoeghe ACD, Ciobanu A, Hodorogea AS, Radavoi GD, Jinga V, Nanea IT, Gheorghe GS; “Evolution of Electrocardiographic Repolarisation Parameters During Antiandrogenic Therapy in Patients with Prostate Cancer and Hypogodadism” Cardiovasc Toxicol 2020, 20(4): 390-400.Doi 10.1007/s12012-020-09566-610.1007/s12012-020-09566-6726684632152959
]Search in Google Scholar
